Omega 3 fatty acids in psychiatry | Zendy

Davor Pavlović | Zendy; Aleksandra Pavlović | Zendy; Maja Lačković | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Omega 3 fatty acids in psychiatry

Author(s) -

Davor Pavlović,

Aleksandra Pavlović,

Maja Lačković

Publication year - 2013

Publication title -

archives of biological sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.217

H-Index - 25

eISSN - 1821-4339

pISSN - 0354-4664

DOI - 10.2298/abs1301043p

Subject(s) - polyunsaturated fatty acid , glutamatergic , serotonergic , schizophrenia (object oriented programming) , depression (economics) , bipolar disorder , dopaminergic , psychiatry , long chain , per capita , medicine , fish <actinopterygii> , lithium (medication) , physiology , chemistry , serotonin , biology , fatty acid , dopamine , glutamate receptor , biochemistry , environmental health , fishery , receptor , polymer science , economics , macroeconomics , population

Omega-3 long-chain polyunsaturated fatty acids (ω-3 LC-PUFAs) are thought to be important for normal dopaminergic, glutamatergic and serotonergic neurotransmission. Depression is less prevalent in societies with high fish consumption, and depressed patients have significantly lower red blood cell ω-3 levels. Studies with ω-3 supplementation have led to controversial results. A significantly longer remission of bipolar symptomatology has been confirmed from a high-dose DHA and EPA mixture. Greater seafood consumption per capita has been connected with a lower prevalence of bipolar spectrum disorders. Reduced levels of ω-6 and ω-3 PUFAs were found in patients with schizophrenia. [Projekat Ministarstva nauke Republike Srbije, br. 175033 i br. 175022

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research